Insider Trading Alert - MJN, JAZZ And CLB Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Feb. 14, 2014, 110 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $2,636.40 to $128,200,000.00.

Highlighted Stocks Traded by Insiders:

Mead Johnson Nutrition Company (MJN) - FREE Research Report

Golsby Stephen W who is Director at Mead Johnson Nutrition Company sold 10,000 shares at $77.78 on Feb. 14, 2014. Following this transaction, the Director owned 80,920 shares meaning that the stake was reduced by 11% with the 10,000-share transaction.

The shares most recently traded at $77.37, down $0.41, or 0.53% since the insider transaction. Historical insider transactions for Mead Johnson Nutrition Company go as follows:

  • 4-Week # shares bought: 500
  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 500
  • 12-Week # shares sold: 30,000
  • 24-Week # shares bought: 500
  • 24-Week # shares sold: 60,525

The average volume for Mead Johnson Nutrition Company has been 1.7 million shares per day over the past 30 days. Mead Johnson Nutrition Company has a market cap of $15.7 billion and is part of the consumer goods sector and food & beverage industry. Shares are down 7.27% year-to-date as of the close of trading on Friday.

Mead Johnson is a subsidiary of Bristol-Myers Squibb Co., see separate record. The stock currently has a dividend yield of 1.75%. The company has a P/E ratio of 23.0. Currently there are 7 analysts that rate Mead Johnson Nutrition Company a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MJN - FREE

TheStreet Quant Ratings rates Mead Johnson Nutrition Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, expanding profit margins, increase in net income and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Mead Johnson Nutrition Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

McCormick in $4.2 Billion Play for Reckitt Benckiser's Food Division

Reckitt Wrecked By Petya Virus

Reckitt Benckiser Says Petya Cyber Attack Will Slam Q2 Revenues

Reckitt to Close $18 Billion Mead Johnson Takeover Deal June 15